期刊文献+

血清胸苷激酶-1与鼻咽癌临床病理特征相关性分析 被引量:7

Correlation of serum thymidine kinase-1 and clinical characteristics of nasopharyngeal carcinoma
原文传递
导出
摘要 目的:观察治疗前鼻咽癌患者血清胸甘激酶1(TK-1)水平与临床特征之间的关系。方法:77例鼻咽癌初治患者(治疗组)治疗前采用酶增强化学发光技术检测TK-1浓度,选取20名健康志愿者为对照组。收集所有患者临床特征资料,并予首程根治性放疗,随访6个月,进行近期疗效评价;所有资料经SPSS 13.0软件统计包处理,进行t检验、检验和单因素方差分析(ANOVA)。结果:治疗组治疗前TK-1浓度(3.60±1.78)ρmol/L高于对照组(0.49±0.37)ρmol/L,t=-7.737,P=0.000;鼻咽癌患者临床特征中颈动脉鞘受累、颅底受侵、颅神经受累、咽后淋巴结肿大、茎突前间隙受侵及VCA-IgA与TK-1浓度有相关性,P值均<0.05;T分期、N分期、临床分期及近期疗效与治疗前TK-1浓度显著相关,P值均<0.05;而TK-1阳性率与茎突后间隙、N分期、临床分期和淋巴结转移部位有相关性,P<0.05。其他临床特征与治疗前TK-1浓度无相关性。结论:鼻咽癌患者在治疗前检测血清TK-1浓度有重要的临床意义;TK-1浓度越高,则临床分期越晚,预后相对较差。 OBJECTIVE:To observe the relationship of TK-1 levels and clinical characteristics of NPC before treatment.METHODS:Enzyme enhanced chemiluminescence was used to detect TK-1 concentration of 77 cases of NPC patients and 20 healthy people considered as the control group.All patients had received radical radiotherapy in the first process and followed up for six months and evaluated the theraputic effect.The methods that were used to analyze the data were t and chi-squre test and single factor analysis of variance(ANOVA).RESULTS: TK-1 levels of NPC group was higher than that in control group(3.60±1.78 ρmol/L vs 0.49±0.37 ρmol/L,t=-7.737,P=0.000);clinical characteristics of NPC,including involvement of carotid sheath,skull base and cranial nerve,retropharyngeal lymph nodes,spare before styloid and VCA-IgA,and TK-1 levels were related(P<0.05);T stage,N stage,clinical stage,the recent efficacy and TK-1 levels was significantly related(P<0.05).Post styloid spact,N staging,clinical stage,lymph node metastasis and the positive rate of TK-1 was related(P<0.05).Other clinical features were not related with TK-1 concentration before treatment.CONCLUSION:The detection of serum TK-1 concentration in NPC patients before treatment has important clinical significance;the high concentration of TK-1 usually indicate the later clinical stage and poor prognosis.
作者 秦雷 杨林
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第2期113-117,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 鼻咽肿瘤 血清胸苷激酶-1 临床特征 相关分析 nasopharyngeal neoplasms Serum thymidine kinase-1 clinical characteristic corvelation analysis
  • 相关文献

参考文献11

  • 1Gasparri F,Wang N,Skog S. Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and array scan assays[J].European Journal of Cell Biology,2009,(12):779-785.
  • 2凤敏华.血清胸苷激酶的检测在肺癌诊断及疗效评估中的意义[J].放射免疫学杂志,2011,24(4):455-456. 被引量:6
  • 3张平安,李艳,邹力,何其敏.消化道癌症患者血清胸苷激酶的检测及临床意义[J].中华医学杂志,2001,81(18):1137-1138. 被引量:14
  • 4Alegre MM,Robison RA,O'Neill KL. Thymidine kinase1 upregulation is an early event in breast tumor formation[J].Journal of Oncology,2012.575647.
  • 5Gronowitz JS,K(a)llander FR,Diderholm H. Application of an in vitro assay for serum thymidine kinase:results on viral diaease and malignaneies in Humans[J].International Journal of Cancer,1984,(01):5-12.
  • 6Lewenhaupt A,Ekman P,Eneroth P. Tumour markers asprognosticaida in prostatic carcinoma[J].British Journal of Urology,1990,(02):1182-1187.
  • 7管燕,郭其森,山凤莲,刘秀菊.小细胞肺癌组织胸苷激酶表达临床意义的研究[J].中华肿瘤防治杂志,2010,17(10):746-748. 被引量:10
  • 8Chen Y,Ying M. Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings[J].International Journal of Clinical Oncology,2010,(04):359-368.
  • 9Li Z,Wang Y,He J. Serological thymidine kinase 1 is a prognostic factor in oesophageal,cardial and lung carcinomas[J].European Journal of Cancer Prevention,2010,(04):313-318.
  • 10Huang S,Lin J,Guo N. Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression[J].Asian PaJ Cancer Prev,2011,(02):497-505.

二级参考文献34

  • 1唐玲珑,刘立志,马骏,宗井凤,黄莹,林爱华,卢泰祥,崔念基.咽后淋巴结转移在鼻咽癌分期中的意义[J].癌症,2006,25(2):129-135. 被引量:28
  • 2Wu C, Yang R, Zhou J, et al. Production and characterization of a novel chicken IgY antibody raised against C terminal peptide from human thymidine kinasel[J]. J Immunol Met hods, 2003, 277(1-2) : 157-169.
  • 3Luo P,He E,Eriksson S, et al. Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker [J]. Eur J Cancer Prey,2009,18(3) :220-224.
  • 4Ohrvik A,Lindh M,Einarsson R, et al. Sensitive nonradiometric method for determining thymidine kinase 1 activity [J]. Clin Chem, 2004,50: 1597-1606.
  • 5Gasparri F, Wang N, Skog S, et al. Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays[J]. Eur J Cell Biol, 2009,88(12) :779-785.
  • 6He Q,Zhang P G,Zou L,et al. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation maker in human solid tumor than its activity [J]. Ontology Report,2007, 14(4) :1013-1019.
  • 7Chen Z, Zhou H, Li S, et al. Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours [J]. Anticaneer Res,2008, 28(6B) :3897-3907.
  • 8Zhang J,Jia Q, Zou S,et alTh. ymidine kinase l:a p roliferation marker for deter mining p rognosis and monit oring the surgical out come of p rimary bladder carcinoma patients [J]. Oncol Rep, 2006,15 (2) : 455-461.
  • 9Brockenbrough J S, Morihara J K, Hawes S E, et al. Thymidine kinase 1 and thymidine phosphorylase expression in non-small- cell lung carcinoma in relation to angiogenesis and proliferation [J]. J Histochem Cytochem, 2009,57(11) : 1087-1097.
  • 10Lewenhaupt A,Ekman P,Eneroth P,et al.Tumour markers asprognosticaids in prostatic carcinoma[J].Br J Urol,1990,66(2):1182-1187.

共引文献31

同被引文献87

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部